Loading
Latest filing published 08 Jun 2026 for Aurinia Pharmaceuticals Inc., €232k. Read the official filing
No signal scores available.
One trade, one date: on 8 June 2026, Tina Nova disclosed an option exercise of €232k in Aurinia Pharmaceuticals Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.